Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


University of Auckland welcomes rheumatic fever initiative

The University of Auckland

18 February 2013

University of Auckland welcomes rheumatic fever initiative

The University of Auckland has welcomed an announcement by the New Zealand and Australian Prime Ministers of funding to investigate potential vaccines against rheumatic fever.

The prime ministers have committed NZ$3 million over two years for a trans-Tasman project to identify vaccines that could be taken into clinical development.

Rheumatic fever can cause life-threatening rheumatic heart disease. The disease is now rare in most wealthy countries, but remains a major health concern in New Zealand and Australia. Māori, Pasifika and Aboriginal communities in particular have amongst the highest rates of rheumatic heart disease in the world.

Rheumatic fever is the result of an immune reaction to infection by group A streptococcus, and vaccination against the bacterium has the potential to prevent the disease. There are many different strains of group A streptococcus worldwide, and the vaccine project will focus on those found in New Zealand and Australia.

The vaccine project complements ongoing public health programs that address the issues which contribute to high rates of the disease in New Zealand and Australia.

“The University has considerable expertise in both the basic science of group A streptococcus infection and the public health approaches required to tackle high rates of rheumatic fever. We’re delighted to have been actively engaged in investigating potential vaccine candidates,” says Professor John Fraser, Dean of the Faculty of Medical and Health Sciences, who is a world expert in streptococcal pathogenesis.

Professor Fraser says that the University looks forward to the release of further details on the project.

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Taxing Multinationals: EU Ruling Sours Apple

Shares of Apple slid, down 0.9 percent as of 3.08pm in New York, after the European Commission ruled that Ireland granted the company undue tax benefits of up to 13 billion euros (US$14.5 billion)—"illegal aid” under EU rules that the commission says Ireland now must recover from Apple. More>>

ALSO:

NZX Review: Best Practice Code Recommends Code Of Ethics

NZX, the sharemarket operator, is seeking feedback on proposed changes to its corporate governance best practice code including a published code of ethics, rules about share trading and continuous disclosure, and more transparency over board appointments and chief executive pay. More>>

ALSO:

Auditors:

Signs Of Life? SETI On Russian Space(?) Signal

A star system 94 light-years away is in the spotlight as a possible candidate for intelligent inhabitants, thanks to the discovery of a radio signal by a group of Russian astronomers... Could it be a transmission from a technically proficient society? At this point, we can only consider what is known so far. More>>

Post-Post: Brian Roche To Step Down As NZ Post CEO

Brian Roche will step down as chief executive of New Zealand Post in April 2017, having led the state-owned postal service's drive to adjust to shrinking mail volumes with a combination of cost cuts, asset sales, modernisation and expansion of new businesses. More>>

ALSO:

Company Results: Air NZ Rides The Tourism Boom With Record Full-Year Earnings

Air New Zealand has ridden the tourism boom and staved off increased competition to deliver the best full-year earnings in its 76-year history. More>>

ALSO:

New PGP: Sheep Milk Industry Gets $12.6M Crown Funding

The Sheep - Horizon Three programme aims to develop "a market driven, end-to-end value chain generating annual revenues of between $200 million and $700 million by 2030," according to a joint statement. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news